Search research articles
Contact Us
Filters
Showing results (11-20 of 128) with videos related to
Page
of 13
Sort By:
BMC Cancer
|
June 3, 2023
Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens
Florestan J Koll, Claudia Döring, Csilla Olah, et al.
European Urology Focus
|
July 9, 2026
Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment
Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al.
European Urology Focus
|
April 13, 2023
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease Volume
Benedikt Hoeh, Cristina Cano Garcia, Mike Wenzel, et al.
Urologia Internationalis
|
December 21, 2023
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies
Séverine Banek, Benedikt Hoeh, Cristina Cano Garcia, et al.
Urologia Internationalis
|
September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated Patients
Mike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
European Urology Oncology
|
September 1, 2024
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis
Mike Wenzel, Cristiana Cano Garcia, Clara Humke, et al.
World Journal of Urology
|
December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Mike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Cancers
|
July 27, 2022
Impact of Statin Use on Localized Prostate Cancer Outcomes after Radiation Therapy: Long-Term Follow-Up
Kevin Kaulanjan, Danny Lavigne, Fred Saad, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
Mike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2025
Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients
Mike Wenzel, Lena Theissen, Daniel Groener, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 128) with videos related to
Sort By:
Page
of 13
BMC Cancer
|
June 3, 2023
Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens
Florestan J Koll, Claudia Döring, Csilla Olah, et al.
European Urology Focus
|
July 9, 2026
Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment
Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al.
European Urology Focus
|
April 13, 2023
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease Volume
Benedikt Hoeh, Cristina Cano Garcia, Mike Wenzel, et al.
Urologia Internationalis
|
December 21, 2023
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies
Séverine Banek, Benedikt Hoeh, Cristina Cano Garcia, et al.
Urologia Internationalis
|
September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated Patients
Mike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
European Urology Oncology
|
September 1, 2024
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis
Mike Wenzel, Cristiana Cano Garcia, Clara Humke, et al.
World Journal of Urology
|
December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Mike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Cancers
|
July 27, 2022
Impact of Statin Use on Localized Prostate Cancer Outcomes after Radiation Therapy: Long-Term Follow-Up
Kevin Kaulanjan, Danny Lavigne, Fred Saad, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy
Mike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2025
Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients
Mike Wenzel, Lena Theissen, Daniel Groener, et al.
Page
of 13